Search Results - Litton, Jennifer Keating

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Exemestane in the prevention setting

    Exemestane in the prevention setting by Litton, Jennifer Keating, Bevers, Therese B., Arun, Banu K.

    Request full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Is Age Still the Deciding Factor? Commentary on “The Effect of Age on Delay in Diagnosis and Stage of Breast Cancer” by Partridge et al

    Is Age Still the Deciding Factor? Commentary on “The Effect of Age on Delay in Diagnosis and Stage of Breast Cancer” by Partridge et al by Keating Litton, Jennifer

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract P2-16-08: Longitudinal response and selection under neoadjuvant systemic therapy (NAST) in triple-negative breast cancer (TNBC): Profiling results from a randomized, TNBC enrolling trial to confirm molecular profiling improves survival (ARTEMIS; NCT02276443)

    Abstract P2-16-08: Longitudinal response and selection under neoadjuvant systemic therapy (NAST) in triple-negative breast cancer (TNBC): Profiling results from a randomized, TNBC... by Seth, Sahil, Huo, Lei, Vasaikar, Suhas, Rauch, Gaiane, Lim, Bora, White, Jason, Adrada, Beatriz, Piwnica-Worms, Helen, Ueno, Naoto T, Thompson, Alastair Mark, Mittendorf, Elizabeth, Tripathy, Debashish, Litton, Jennifer Keating, Symmans, William Fraser, Draetta, Giulio, Futreal, Andrew, Chang, Jeffrey, Moulder, Stacy

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    High incidence of germline BRCA mutation in patients with ER low‐positive/PR low‐positive/HER‐2 neu negative tumors

    High incidence of germline BRCA mutation in patients with ER low‐positive/PR low‐positive/HER‐2 neu negative tumors by Sanford, Rachel A., Song, Juhee, Gutierrez‐Barrera, Angelica M., Profato, Jessica, Woodson, Ashley, Litton, Jennifer Keating, Bedrosian, Isabelle, Albarracin, Constance T., Valero, Vicente, Arun, Banu

    Published in Cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Patient-reported outcomes (PROs) in patients (pts) with advanced breast cancer (aBC) and a germline BRCA1/2 mutation (gBRCAm) receiving talazoparib (TALA) vs physician’s choice chemotherapy treatment (PCT): a focus on the EMBRACA HR+/HER2- subpopulation

    Patient-reported outcomes (PROs) in patients (pts) with advanced breast cancer (aBC) and a germline BRCA1/2 mutation (gBRCAm) receiving talazoparib (TALA) vs physician’s choice che... by Hurvitz, Sara A., Quek, Ruben G.W., Ettl, Johannes, Rugo, Hope, Bhattacharyya, Helen, Hannah, Alison L., Litton, Jennifer Keating

    Published in Breast (Edinburgh)
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: